The Technical Analyst
SI-BONE Inc [SIBN]
Exchange: NASDAQ Sector: Healthcare Industry: Medical Devices
SI-BONE Inc Price, Forecast, Insider, Ratings, Fundamentals & Signals
Current Signal: BUY (auto-tracking)
-5.37% $14.27
America/New_York / 25 apr 2024 @ 16:00
| FUNDAMENTALS | |
|---|---|
| MarketCap: | 585.99 mill |
| EPS: | -1.130 |
| P/E: | -12.63 |
| Earnings Date: | May 06, 2024 |
| SharesOutstanding: | 41.06 mill |
| Avg Daily Volume: | 0.428 mill |
| RATING 2024-04-25 |
|---|
| B- |
| Neutral |
| RATINGS | ||
|---|---|---|
| Rating CashFlow: | Sell | |
| Return On Equity: | Sell | |
| Return On Asset: | Sell | |
| DE: | Buy | |
| P/E: | Strong Sell | |
| Price To Book: | Buy |
| QUARTER GROWTHS | ||||||
|---|---|---|---|---|---|---|
| 3/22 | 4/22 | 1/23 | 2/23 | 3/23 | 4/23 | |
| Revenue | ||||||
| Gr.Profit | ||||||
| Ebit | ||||||
| Asset | ||||||
| Debt |
| PE RATIO: COMPANY / SECTOR |
|---|
| 0.00x |
| Company: PE -12.63 | sector: PE -3.05 |
| PE RATIO: COMPANY / INDUSTRY |
|---|
| -0.06x |
| Company: PE -12.63 | industry: PE 222.16 |
| DISCOUNTED CASH FLOW VALUE |
|---|
| N/A |
| N/A |
| Expected Trading Range (DAY) |
|---|
|
$ 13.61 - 14.93 ( +/- 4.60%) |
| ATR Model: 14 days |
Insider Trading
| Date | Person | Action | Amount | type |
|---|---|---|---|---|
| 2024-04-02 | Recupero Anthony J | Sell | 1 555 | Common Stock |
| 2024-04-02 | Recupero Anthony J | Sell | 1 752 | Common Stock |
| 2024-04-03 | Recupero Anthony J | Sell | 920 | Common Stock |
| 2024-04-02 | Maheshwari Anshul | Sell | 1 140 | Common Stock |
| 2024-04-02 | Maheshwari Anshul | Sell | 1 285 | Common Stock |
| INSIDER POWER |
|---|
| 20.98 |
| Last 100 transactions |
| Buy: 453 308 | Sell: 383 933 |
Forecast:
16:00 - $14.27
Live Trading Signals (every 1 min)
Forecast
1: 16:00 - $14.27
Forecast 2: 16:00 - $14.27
Forecast 3: 16:00 - $14.27
SCORE
10.00
Buy
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Last version updated: Fri April 15th, 2022
| Indicator Signals | |
|---|---|
| RSI 21 | |
| SMA | |
| Trend | |
| Trend 2 | |
| Trend 3 | |
| MACD |
| Volume Signals | |
|---|---|
| Price | $14.27 (-5.37% ) |
| Volume | 0.226 mill |
| Avg. Vol. | 0.428 mill |
| % of Avg. Vol | 52.74 % |
| Signal 1: | |
| Signal 2: |
Today
Last 12 Months
RSI
Last 10 Buy & Sell Signals For SIBN
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
| Date | Signal | @ | Closed | % | Feb 8 - 15:31 | buy | $20.82 | N/A | Active |
|---|
SIBN
SI-BONE, Inc., a medical device company, develops implantable devices used to solve musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally. It offers iFuse, a minimally invasive surgical implant system to address sacroiliac joint dysfunction and degeneration, adult deformity, and pelvic ring traumatic fractures. The company also provides iFuse-3D, a titanium implant that combines the triangular cross-section of the iFuse implant with the proprietary 3D-printed porous surface and fenestrated design; and iFuse-TORQ, a set of 3D-printed threaded implants designed to treat fractures of the pelvis and for minimally invasive sacroiliac joint fusion. It markets its products primarily with a direct sales force, as well as through distributors. The company was incorporated in 2008 and is headquartered in Santa Clara, California.
Last 10 Buy Signals
Latest Press Releases
2024-04-15 16:09:00 - Press Release
Si-bone To Report First Quarter 2024 Financial Results On May 6, 2024
Santa clara, calif., april 15, 2024 (globe newswire) -- si-bone, inc. (nasdaq: sibn), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy today announced it will report financial results for the first quarter of 2024 after market close on monday, may 6, 2024. management will host a corresponding conference call beginning at 1:30 p.m. pacific time / 4:30 p.m. eastern time.
2024-03-04 16:09:00 - Press Release
Si-bone To Present At Barclays 26th Annual Global Healthcare Conference On March 12, 2024
Santa clara, calif., march 04, 2024 (globe newswire) -- si-bone, inc. (nasdaq: sibn), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today announced that the company will be participating in the upcoming barclays 26th annual global healthcare conference in miami. management will be hosting a fireside chat on tuesday, march 12, at 8:30 a.m. eastern time / 5:30 a.m. pacific time.
2024-02-26 16:09:00 - Press Release
Si-bone, Inc. Reports Record Fourth Quarter And Full Year 2023 Financial Results And Issues 2024 Guidance
Santa clara, calif., feb. 26, 2024 (globe newswire) -- si-bone, inc. (nasdaq: sibn), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today reported financial results for the fourth quarter and full year ended december 31, 2023.
2024-02-05 16:09:00 - Press Release
Si-bone To Report Fourth-quarter And Full-year 2023 Financial Results On February 26, 2024
Santa clara, calif., feb. 05, 2024 (globe newswire) -- si-bone, inc. (nasdaq: sibn), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today announced it will report financial results for the fourth quarter and full year ended december 31, 2023 after market close on monday, february 26, 2024. management will host a conference call beginning at 1:30 p.m. pacific time / 4:30 p.m. eastern time.
2024-01-30 08:30:00 - Press Release
Si-bone, Inc. Receives Fda 510(k) Clearance For A Smaller Diameter Ifuse Bedrock Granite Implant With An Expanded Indication And Application
Santa clara, calif., jan. 30, 2024 (globe newswire) -- si-bone, inc., (nasdaq: sibn), a silicon valley-based medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, announces fda 510(k) premarket clearance of the ifuse bedrock granite® implant system (granite) in a smaller (9.5 mm) diameter with both an expanded indication in pediatric patients and an expanded application that includes use in the s1 trajectory. when placed across the si joint, the granite implant provides sacroiliac fusion and sacropelvic fixation as a foundational element for multi-segment spinal fusion.
Latest News
2024-04-15 16:09:00 - GlobeNewsWire
SI-BONE To Report First Quarter 2024 Financial Results on May 6, 2024
SANTA CLARA, Calif., April 15, 2024 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy today announced it will report financial results for the first quarter of 2024 after market close on Monday, May 6, 2024. Management will host a corresponding conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time.
2024-03-04 16:09:00 - GlobeNewsWire
SI-BONE to Present at Barclays 26th Annual Global Healthcare Conference on March 12, 2024
SANTA CLARA, Calif., March 04, 2024 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today announced that the company will be participating in the upcoming Barclays 26th Annual Global Healthcare Conference in Miami. Management will be hosting a fireside chat on Tuesday, March 12, at 8:30 a.m. Eastern Time / 5:30 a.m. Pacific Time.
2024-02-19 11:05:33 - Zacks Investment Research
Si-Bone (SIBN) Expected to Beat Earnings Estimates: What to Know Ahead of Q4 Release
Si-Bone (SIBN) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
2024-02-05 16:09:00 - GlobeNewsWire
SI-BONE To Report Fourth-Quarter and Full-Year 2023 Financial Results on February 26, 2024
SANTA CLARA, Calif., Feb. 05, 2024 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today announced it will report financial results for the fourth quarter and full year ended December 31, 2023 after market close on Monday, February 26, 2024. Management will host a conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time.
2024-01-31 09:51:07 - Zacks Investment Research
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.
2023-11-16 12:47:44 - Seeking Alpha
Sizing Up SI-BONE After Q3 Earnings
Today, we take a look at SI-BONE, Inc., a medical device company focused on developing implantable devices for musculoskeletal disorders. The company is targeting a large potential market, delivers consistent sales growth, and has a solid balance sheet. However, SI-BONE is some years away from profitability and the shares have seen some considerable insider selling in 2023.
2023-11-14 16:09:00 - GlobeNewsWire
SI-BONE To Present at Piper Sandler 35th Annual Healthcare Conference on November 28, 2023
SANTA CLARA, Calif., Nov. 14, 2023 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today announced that the company will be participating in the upcoming Piper Sandler Healthcare Conference in New York. Management will be hosting a fireside chat on Tuesday, November 28, 2023, at 3:30 p.m. Eastern Time / 12:30 p.m. Pacific Time.
2023-11-06 21:22:09 - Seeking Alpha
SI-BONE, Inc. (SIBN) Q3 2023 Earnings Call Transcript
SI-BONE, Inc. (NASDAQ:SIBN ) Q3 2023 Earnings Conference Call November 6, 2023 4:30 PM ET Company Participants Saqib Iqbal - Senior Director of IR Laura Francis - CEO Anshul Maheshwari - CFO Conference Call Participants Young Li - Jefferies Drew Ranieri - Morgan Stanley Craig Bijou - Bank of America David Saxon - Needham & Company Dave Turkaly - JMP Securities Caitlin Cronin - Canaccord Samuel Brodovsky - Truist Securities Operator Good afternoon and welcome to SI-BONE's Third Quarter Earnings Conference Call. At this time, all participants are in a listen-only mode.
2023-11-01 16:09:00 - GlobeNewsWire
SI-BONE To Present at Jefferies London Healthcare Conference on November 15, 2023
SANTA CLARA, Calif., Nov. 01, 2023 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today announced that the company will be participating in the upcoming Jefferies London Healthcare Conference in London, UK. Management will be hosting a fireside chat on Wednesday, November 15, 2023, at 4:00 a.m. Eastern Time / 1:00 a.m. Pacific Time.
2023-10-16 16:09:00 - GlobeNewsWire
SI-BONE to Report Third Quarter 2023 Financial Results on November 6, 2023
SANTA CLARA, Calif., Oct. 16, 2023 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today announced it will report financial results for the third quarter of 2023 after market close on Monday, November 6, 2023. Management will host a corresponding conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time.